AMY SIMMONS: Open Payments
NPI 1366953143 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 28 payments from 10 companies in 2025. Trend: 2023 $319 · 2024 $420 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $150 |
| Novo Nordisk Inc | 6 | $129 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Lilly USA, LLC | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 2 | $58 |
| Astellas Pharma US Inc | 2 | $49 |
| Exact Sciences Corporation | 2 | $44 |
| Amgen Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, Ozempic, MOUNJARO, VOQUEZNA, Veozah, Cologuard Collection Kit, EVENITY.
Industry payments across AZ — which companies pay providers there.
